|William Davis Gaillard, MD, Named to the Board of Directors of the American Epilepsy Society (AES)
December 16, 2009
William Davis Gaillard, MD, Named to the Board of Directors of the American Epilepsy Society (AES)
Washington, DC - William Davis Gaillard, MD, chief of the division of Epilepsy and Neurophysiology at Children’s National Medical Center and professor of Pediatrics and Neurology at George Washington University, was elected to the Board of Directors of the American Epilepsy Society (AES) at its annual meeting last week.
The AES, based in West Hartford, Conn., is the premier professional and scientific organization focused on research and care of people with epilepsy. The society is a multidisciplinary endeavor of basic and translational research scientists, child and adult neurologists, neurosurgeons, neuropsychologists, psychiatrists, and allied health professionals.
“I am pleased to serve on the board of an organization that has done so much to advance the understanding and treatment of epilepsy,” said Dr. Gaillard. “Of the approximately 5 million people with epilepsy, more than half developed the condition in childhood, making pediatric epilepsy an essential area for research and treatment breakthroughs.”
Children’s faculty have played – and continue to play – a leading role in the AES: chairing AES committees, organizing research and clinical care symposia, and helping to oversee society research funding. This year, as in recent years, Children’s National presented more scientific abstracts than any other pediatric epilepsy medical program. Phillip Pearl, MD, division chief of General Neurology at Children’s National, directed the 2009 Pediatric State of the Art Symposium, the main AES educational and research venue for childhood epilepsy.
Dr. Gaillard is an internationally recognized expert in pediatric epilepsy and imaging. He has worked throughout his career to study the effects of childhood epilepsy on brain structure and function. He helped pioneer brain mapping with functional MRI in pediatric populations, and continues to focus on determining the impact of seizures on language, cognitive, behavioral, and emotional development.
Children’s National has one of the largest multidisciplinary epilepsy programs in the country, with more than 8,000 epilepsy-related patient visits each year. Its innovative clinical and research program evaluates and cares for children from the onset of seizures, through advanced imaging technology, novel therapeutic interventions, medication trials, and surgery for children with chronic epilepsy. Treatment at Children’s National addresses the problems of difficult-to-control epilepsy, as well as the concurrent social, educational, and emotional issues faced by children with the condition and their families.
Contact: Paula Darte or Jennifer Leischer: 202-476-4500.
# # #
About Children’s National Medical Center
Children's National Medical Center, located in Washington, DC, is a proven leader in the development of innovative new treatments for childhood illness and injury. Children’s has been serving the nation's children for more than 135 years. Children’s National is proudly ranked among the best pediatric hospitals in America by US News & World Report and the Leapfrog Group. For more information, visit www.childrensnational.org. Children’s Research Institute, the academic arm of Children’s National Medical Center, encompasses the translational, clinical, and community research efforts of the institution. Learn more about our research programs at www.childrensnational.org/research.